{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:06:16Z","timestamp":1783933576935,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":118,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.prdoa.2026.100447","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T22:59:34Z","timestamp":1777762774000},"page":"100447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rotigotine and parkinsonism-hyperpyrexia syndrome"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-9976","authenticated-orcid":false,"given":"Shohei","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Hasuike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosho","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8706-4231","authenticated-orcid":false,"given":"Masataka","family":"Igeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-7227","authenticated-orcid":false,"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement 1","key":"10.1016\/j.prdoa.2026.100447_b0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1353-8020(02)00125-6","article-title":"Malignant syndrome in Parkinson\u2019s disease: Concept and review of the literature","volume":"9","author":"Mizuno","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Supplement 1","key":"10.1016\/j.prdoa.2026.100447_b0010","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S1353-8020(02)00122-0","article-title":"A collaborative study on the malignant syndrome in Parkinson\u2019s disease and related disorders","volume":"9","author":"Takubo","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Supplement 1","key":"10.1016\/j.prdoa.2026.100447_b0015","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S1353-8020(02)00123-2","article-title":"Prevention and treatment of malignant syndrome in Parkinson\u2019s disease: a consensus statement of the malignant syndrome research group","volume":"9","author":"Ikebe","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Supplement 1","key":"10.1016\/j.prdoa.2026.100447_b0020","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S1353-8020(02)00119-0","article-title":"Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson\u2019s disease","volume":"9","author":"Hashimoto","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.prdoa.2026.100447_b0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0038-1677050","article-title":"Movement disorders emergencies","volume":"39","author":"Rajan","year":"2019","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.prdoa.2026.100447_b0030","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3233\/JPD-223362","article-title":"Parkinsonism-hyperpyrexia syndrome and dyskinesia-hyperpyrexia syndrome in Parkinson\u2019s disease: two cases and literature review","volume":"12","author":"Wang","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.prdoa.2026.100447_b0035","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000252355.79284.22","article-title":"Randomized, blind, controlled trial of transdermal Rotigotine in early Parkinson disease","volume":"68","author":"Watts","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2026.100447_b0040","first-page":"281","article-title":"A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson\u2019s disease resolved with rotigotine: a case report","volume":"85","author":"Fiore","year":"2014","journal-title":"Acta Biomed"},{"key":"10.1016\/j.prdoa.2026.100447_b0045","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2026.100447_b0050","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.prdoa.2026.100447_b0055","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"International Parkinson and Movement Disorders Society Non-motor Parkinson Disease Study Group, Levodopa dose equivalency in Parkinson\u2019s disease: Updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2026.100447_b0060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.prdoa.2026.100447_b0065","first-page":"973","article-title":"Rotigotine","volume":"19","author":"Reynolds","year":"2005","journal-title":"In Parkinson\u2019s Disease, in: CNS Drugs."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112526000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112526000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:19:46Z","timestamp":1783930786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112526000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":13,"alternative-id":["S2590112526000277"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2026.100447","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rotigotine and parkinsonism-hyperpyrexia syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2026.100447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100447"}}